• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.64% Nasdaq Down0.55%

    United Therapeutics Corporation (UTHR)

    -NasdaqGS
    183.72 Up 1.87(1.03%) May 29, 4:00PM EDT
    |After Hours : 183.71 Down 0.01 (0.01%) May 29, 7:07PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 1,288,519   1,116,984   916,076  
    Cost of Revenue125,883  131,127  119,297  
    Gross Profit 1,162,636   985,857   796,779  
    Operating Expenses
    Research Development242,549  299,348  173,387  
    Selling General and Administrative381,287  394,010  201,746  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 538,800   292,499   421,646  
    Income from Continuing Operations
    Total Other Income/Expenses Net3,972  4,462  35,664  
    Earnings Before Interest And Taxes542,772  296,961  457,310  
    Interest Expense17,592  18,058  16,639  
    Income Before Tax525,180  278,903  440,671  
    Income Tax Expense185,106  104,343  136,229  
    Minority Interest -   -   -  
    Net Income From Continuing Ops340,074  174,560  304,442  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 340,074   174,560   304,442  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 340,074   174,560   304,442  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.